A

Afrocentric Investment Corporation Ltd
JSE:ACT

Watchlist Manager
Afrocentric Investment Corporation Ltd
JSE:ACT
Watchlist
Price: 146 Zac -0.68% Market Closed
Market Cap: 13m ZAR

Afrocentric Investment Corporation Ltd
Investor Relations

Afrocentric Investment Corporation Ltd., nestled in the heart of Johannesburg, stands as a significant torchbearer in the healthcare industry across the African continent. Founded in 2006, the company embarked on a mission to revolutionize health services in a region often challenged by access and affordability barriers. Leveraging its impressive tapestry of subsidiaries, including Medscheme Holdings and Pharmacy Direct, Afrocentric orchestrates a broad spectrum of healthcare solutions. Medscheme, a cornerstone of its operations, functions as a prominent medical scheme administrator, navigating the complexities of health insurance for over three million lives. It marries efficiency with service excellence, ensuring schemes remain solvent and members receive optimal care. On a parallel track, Pharmacy Direct complements this by spearheading the distribution of chronic medication at scale, emphasizing affordability and an unwavering commitment to improving patient health outcomes.

The revenue engine of Afrocentric churns primarily through administrative fees garnered from managed care services, alongside income from its broad healthcare service offerings. Its deep integration into the healthcare value chain allows the company to capitalize on economies of scale, fostering both financial growth and value creation for its stakeholders. The strategic acquisition and partnership strategy underpin Afrocentric’s successful expansion, enabling it to infiltrate various facets of the healthcare ecosystem, from distribution networks to health IT solutions. Furthermore, the company's venture into innovative health solutions, backed by technology and analytics, positions it as a forward-thinking leader within the sector. Afrocentric's story is one of strategic foresight and dynamic evolution, grounded in the ambition to redefine Africa’s healthcare landscape.

Show more
No Earnings Calls Available

Management

Mr. Gerald Van Wyk
Group CEO & Director
No Bio Available
Mr. Avsharn Bachoo Ph.D.
Group Technology Director
No Bio Available
Mr. Billy Mokale B Proc, DIP Co LAW, LLB, PMD
GM of Legal, Risk, Governance & Compliance
No Bio Available
Ms. Tebogo Makoe EMBA, M.A.
Group Executive of Human Capital & Transformation
No Bio Available
Ms. Lebohang Mpumlwana
Group Company Secretary
No Bio Available

Contacts

Address
GAUTENG
Roodepoort
37 Conrad Street, Florida North
Contacts